Business & Regulation

Business & Regulation Trends & Forecasts

Welcome to CPhI Europe!

10/08/2024 | Rob Coker

The highlights of the trade show and its conference agenda - day 1

Business & Regulation Standards & Regulation

FDA Warning Letters: September 2024 Edition

10/07/2024 | Stephanie Vine | 3 min read

Here’s a look at recent violations cited in FDA Warning Letters: fly pupae, cross contamination, trial dosing errors, and more.

Business & Regulation Trends & Forecasts

Innovate, Collaborate, and Make Medicines Accessible

10/04/2024

Michael Altorfer, CEO, Swiss Biotech Association, gives his view on the future of drug development.

Business & Regulation Trends & Forecasts

The Multifaceted Future of Pharma

10/03/2024 | Stephanie Vine

We asked over 100 industry professionals for their views on the future of the pharma and biopharma industries.

Business & Regulation Business Practice

Driving the Future of Biopharma

10/01/2024 | Rob Coker

Biopharma companies procrastinating on sustainability measures risk falling behind, according to Cytiva’ Global Biopharma Sustainability Review.

Business & Regulation Profession

Words of Wisdom

09/30/2024 | Stephanie Vine

A look back at some of the most inspiring quotes from our interviews.

Business & Regulation Standards & Regulation

AstraZeneca Flu Vaccine Approved For Self-Administration

09/26/2024 | Rob Coker

AstraZeneca’s FluMist is the first flu vaccine to be approved for self-administration.

Business & Regulation Supply Chain

Towards More Resilient Supply

09/23/2024 | 5 min read

Supply chain lessons have been learned since COVID-19, so why are we seeing so many drug shortages?

Business & Regulation Trends & Forecasts

The Building Blocks of Engagement

09/09/2024 | Aaron Bean | 3 min read

Shifting trends demand a change in how pharma field reps interact with healthcare professionals

Business & Regulation Digital Technologies

The Changing Landscape of Decentralized Clinical Trials

09/06/2024 | Diane Leclerc | 2 min read

How technology is enabling new access to clinical trials for those without the means to participate in traditional methods

Business & Regulation Standards & Regulation

The Demands and Ethical Obligations of the DSCSA

09/02/2024 | Matt Sample, Gregg Gorniak | 3 min read

The deadline for the US Drug Supply Chain Security Act is approaching.

Business & Regulation Supply Chain

Where Have All the Drugs Gone?

08/28/2024 | 6 min read

Drug shortages are everywhere. We speak with Vimala Raghavendran at the US Pharmacopeia to get the full picture.

Business & Regulation COVID-19

Mpox Emergency

08/27/2024 | Rob Coker | 2 min read

Vaccine manufacturers invited to take on mpox challenges